{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["58(1)"],"submitter":["El-Sarnagawy G"],"pubmed_abstract":["<h4>Background</h4>Suicidal poisoning is a major concern during the COVID-19 pandemic that has several physical and mental hazards. This study aimed to evaluate the characteristics of suicidal poisoned patients admitted to a tertiary poison control center during the pandemic lockdown and assess COVID-related knowledge and attitude among those patients to identify the high-risk group for suicide. This cross-sectional study was conducted on acutely poisoned patients admitted to Tanta University Poison Control Center from June to December 2020. Upon admission, socio-demographic data, causative poisoning agents, COVID-related knowledge and attitude, Hamilton Anxiety Rating Scale (HAM-A), and Hamilton Depression Rating Scale (HAM-D) were collected from all participants.<h4>Results</h4>A total of 254 poisoned patients were categorized into suicidal (85.04%) and accidental (14.96%) poisoning groups. The former was caused mainly by phosphides and was significantly associated with a history of using psychotropic medications and high HAM-A and HAM-D results. Logistic regression analysis showed that a history of psychiatric illness, low attitude scores, and high HAM-D scores were significant risk factors for suicidal poisoning.<h4>Conclusions</h4>Considerable number of suicidal poisoned patients had moderate-to-severe depressive symptoms, highlighting the importance of providing specialized psychiatric services in poisoning centers, particularly among vulnerable populations, to prevent the overwhelming repeated suicidal attempts.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1186/s41983-022-00577-4."],"journal":["The Egyptian journal of neurology, psychiatry and neurosurgery"],"pagination":["138"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9684898"],"repository":["biostudies-literature"],"pubmed_title":["Characteristics of suicidal poisoned patients admitted to tertiary care center during COVID-19 pandemic."],"pmcid":["PMC9684898"],"pubmed_authors":["Hafez A","Amer R","El-Sarnagawy G"],"additional_accession":[]},"is_claimable":false,"name":"Characteristics of suicidal poisoned patients admitted to tertiary care center during COVID-19 pandemic.","description":"<h4>Background</h4>Suicidal poisoning is a major concern during the COVID-19 pandemic that has several physical and mental hazards. This study aimed to evaluate the characteristics of suicidal poisoned patients admitted to a tertiary poison control center during the pandemic lockdown and assess COVID-related knowledge and attitude among those patients to identify the high-risk group for suicide. This cross-sectional study was conducted on acutely poisoned patients admitted to Tanta University Poison Control Center from June to December 2020. Upon admission, socio-demographic data, causative poisoning agents, COVID-related knowledge and attitude, Hamilton Anxiety Rating Scale (HAM-A), and Hamilton Depression Rating Scale (HAM-D) were collected from all participants.<h4>Results</h4>A total of 254 poisoned patients were categorized into suicidal (85.04%) and accidental (14.96%) poisoning groups. The former was caused mainly by phosphides and was significantly associated with a history of using psychotropic medications and high HAM-A and HAM-D results. Logistic regression analysis showed that a history of psychiatric illness, low attitude scores, and high HAM-D scores were significant risk factors for suicidal poisoning.<h4>Conclusions</h4>Considerable number of suicidal poisoned patients had moderate-to-severe depressive symptoms, highlighting the importance of providing specialized psychiatric services in poisoning centers, particularly among vulnerable populations, to prevent the overwhelming repeated suicidal attempts.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1186/s41983-022-00577-4.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T23:44:50.851Z","creation":"2025-02-19T01:56:07.224Z"},"accession":"S-EPMC9684898","cross_references":{"pubmed":["36467866"],"doi":["10.1186/s41983-022-00577-4"]}}